Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples